Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Transcoronary transplantation of progenitor cells after myocardial infarction

Article Abstract:

A study investigates whether intracoronary infusion of progenitor cells into the infarct-related artery at least three months after myocardial infarction improves global and regional left ventricular function. Evidence suggests that intracoronary infusion of progenitor cells is safe and feasible in patients with healed myocardial infarction, and that transplantation of bone marrow (BMC) is associated with moderate but significant improvement in the left ventricular ejection fraction after three months.

Author: Dimmeler, Stefanie, Zeiher, Andreas M., Abolmaali, Nasreddin D., Schachinger, Volker, Assmus, Birgit, Tonn, Torsten, Honold, Jorg, Britten, Martina B., Fischer-Rasokat, Ulrich, Lehmann, Ralf, Teupe, Claudius, Pistorius, Katrin, Martin, Hans
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
New England States, Care and treatment, Cells, Cardiac patients, Cell transplantation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Prognostic value of placental growth factor in patients with acute chest pain

Article Abstract:

Increased blood levels of a protein called placental growth factor may be a risk factor for heart attack in patients with chest pain from coronary artery disease, according to a study of 1,173 patients. Those with elevated placental growth factor were three times more likely to have a heart attack within 30 days than other patients. Placental growth factor may increase during inflammation.

Author: Simoons, Maarten L., Hamm, Christian W., Heeschen, Christopher, Dimmeler, Stefanie, Zeiher, Andreas M., Fichtlscherer, Stephan, Berger, Juergen
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
Growth factors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Soluble CD40 ligand in acute coronary syndromes

Article Abstract:

Increased blood levels of soluble CD40 ligand in patients with coronary artery disease is a risk factor for heart attack and death, according to a study of 1,088 patients. This protein occurs on cells involved in blood clotting and is shed into the bloodstream when these cells are activated. It can cause inflammation in this state, which can worsen the patient's prognosis.

Author: Boersma, Eric, Hamm, Christian W., Heeschen, Christopher, Dimmeler, Stefanie, Brand, Marcel J. van den, Zeiher, Andreas M., Simoons, Marten L.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Physiological aspects, Coronary heart disease, Ligands (Biochemistry)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Heart attack, Risk factors
Similar abstracts:
  • Abstracts: Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? Early intensive vs a delayed conservative simvastatin strategy in pateints with acute coronary syndromes: Phase Z of the A to Z trial
  • Abstracts: The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction
  • Abstracts: The clinical spectrum of hepatitis C virus in HIV coinfection. New centers for disease control and prevention's guidelines on HIV counseling and testing for the general population and pregnant women
  • Abstracts: Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: Implications for patient care
  • Abstracts: Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.